Showing 19,381 - 19,400 results of 105,721 for search '(( a we decrease ) OR ( 50 ((((teer decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.20s Refine Results
  1. 19381

    Locational under-representation of certain RNA-editing events in polytracts. by Hui Yu (27723)

    Published 2020
    “…<p>By setting the directionality option of Polytrap to “under,” we switched to investigate the under-representation tendency of three classes of RNA-editing events in polytracts, and found A-to-G events were under-represented in almost all polytract species, excluding A/T, ACC, and hinges. …”
  2. 19382

    Image_4_GLIPR2: a potential biomarker and therapeutic target unveiled – Insights from extensive pan-cancer analyses, with a spotlight on lung adenocarcinoma.tif by Wei Lin (6475)

    Published 2024
    “…Notably, patients with LUAD exhibited a significant decrease in GLIPR2 expression within practical clinical settings. …”
  3. 19383

    Table_7_GLIPR2: a potential biomarker and therapeutic target unveiled – Insights from extensive pan-cancer analyses, with a spotlight on lung adenocarcinoma.xlsx by Wei Lin (6475)

    Published 2024
    “…Notably, patients with LUAD exhibited a significant decrease in GLIPR2 expression within practical clinical settings. …”
  4. 19384

    Image_2_GLIPR2: a potential biomarker and therapeutic target unveiled – Insights from extensive pan-cancer analyses, with a spotlight on lung adenocarcinoma.tif by Wei Lin (6475)

    Published 2024
    “…Notably, patients with LUAD exhibited a significant decrease in GLIPR2 expression within practical clinical settings. …”
  5. 19385

    Table_3_GLIPR2: a potential biomarker and therapeutic target unveiled – Insights from extensive pan-cancer analyses, with a spotlight on lung adenocarcinoma.xlsx by Wei Lin (6475)

    Published 2024
    “…Notably, patients with LUAD exhibited a significant decrease in GLIPR2 expression within practical clinical settings. …”
  6. 19386

    Table_10_GLIPR2: a potential biomarker and therapeutic target unveiled – Insights from extensive pan-cancer analyses, with a spotlight on lung adenocarcinoma.xlsx by Wei Lin (6475)

    Published 2024
    “…Notably, patients with LUAD exhibited a significant decrease in GLIPR2 expression within practical clinical settings. …”
  7. 19387

    Image_3_GLIPR2: a potential biomarker and therapeutic target unveiled – Insights from extensive pan-cancer analyses, with a spotlight on lung adenocarcinoma.tif by Wei Lin (6475)

    Published 2024
    “…Notably, patients with LUAD exhibited a significant decrease in GLIPR2 expression within practical clinical settings. …”
  8. 19388

    Image_1_GLIPR2: a potential biomarker and therapeutic target unveiled – Insights from extensive pan-cancer analyses, with a spotlight on lung adenocarcinoma.tif by Wei Lin (6475)

    Published 2024
    “…Notably, patients with LUAD exhibited a significant decrease in GLIPR2 expression within practical clinical settings. …”
  9. 19389

    Table_6_GLIPR2: a potential biomarker and therapeutic target unveiled – Insights from extensive pan-cancer analyses, with a spotlight on lung adenocarcinoma.xlsx by Wei Lin (6475)

    Published 2024
    “…Notably, patients with LUAD exhibited a significant decrease in GLIPR2 expression within practical clinical settings. …”
  10. 19390

    Image_6_GLIPR2: a potential biomarker and therapeutic target unveiled – Insights from extensive pan-cancer analyses, with a spotlight on lung adenocarcinoma.tif by Wei Lin (6475)

    Published 2024
    “…Notably, patients with LUAD exhibited a significant decrease in GLIPR2 expression within practical clinical settings. …”
  11. 19391

    Table_2_GLIPR2: a potential biomarker and therapeutic target unveiled – Insights from extensive pan-cancer analyses, with a spotlight on lung adenocarcinoma.xlsx by Wei Lin (6475)

    Published 2024
    “…Notably, patients with LUAD exhibited a significant decrease in GLIPR2 expression within practical clinical settings. …”
  12. 19392

    Table_9_GLIPR2: a potential biomarker and therapeutic target unveiled – Insights from extensive pan-cancer analyses, with a spotlight on lung adenocarcinoma.xlsx by Wei Lin (6475)

    Published 2024
    “…Notably, patients with LUAD exhibited a significant decrease in GLIPR2 expression within practical clinical settings. …”
  13. 19393

    Table_5_GLIPR2: a potential biomarker and therapeutic target unveiled – Insights from extensive pan-cancer analyses, with a spotlight on lung adenocarcinoma.xlsx by Wei Lin (6475)

    Published 2024
    “…Notably, patients with LUAD exhibited a significant decrease in GLIPR2 expression within practical clinical settings. …”
  14. 19394

    Image_5_GLIPR2: a potential biomarker and therapeutic target unveiled – Insights from extensive pan-cancer analyses, with a spotlight on lung adenocarcinoma.tif by Wei Lin (6475)

    Published 2024
    “…Notably, patients with LUAD exhibited a significant decrease in GLIPR2 expression within practical clinical settings. …”
  15. 19395

    Table_4_GLIPR2: a potential biomarker and therapeutic target unveiled – Insights from extensive pan-cancer analyses, with a spotlight on lung adenocarcinoma.xlsx by Wei Lin (6475)

    Published 2024
    “…Notably, patients with LUAD exhibited a significant decrease in GLIPR2 expression within practical clinical settings. …”
  16. 19396

    Table_1_GLIPR2: a potential biomarker and therapeutic target unveiled – Insights from extensive pan-cancer analyses, with a spotlight on lung adenocarcinoma.xlsx by Wei Lin (6475)

    Published 2024
    “…Notably, patients with LUAD exhibited a significant decrease in GLIPR2 expression within practical clinical settings. …”
  17. 19397

    Table_8_GLIPR2: a potential biomarker and therapeutic target unveiled – Insights from extensive pan-cancer analyses, with a spotlight on lung adenocarcinoma.xlsx by Wei Lin (6475)

    Published 2024
    “…Notably, patients with LUAD exhibited a significant decrease in GLIPR2 expression within practical clinical settings. …”
  18. 19398
  19. 19399

    Association of Survivin Polymorphisms with Tumor Susceptibility: A Meta-Analysis by Ying Zhu (90057)

    Published 2013
    “…In subgroup analyses of tumor types, we found a significant association between this SNP and an increased risk of gastric, colorectal, bladder and other tumors as well as a decreased risk of hepatocellular cancer. …”
  20. 19400

    Validation of mCherry fluorescence as a proxy for growth measurements. by Chiara Rezzoagli (9253270)

    Published 2020
    “…We therefore used mCherry fluorescence, constitutively expressed from a single-copy chromosomal insertion, as a proxy for bacterial growth in CAS. …”